Bortezomib (BOR)-Thalidomide-Dexamethasone (VTD) as induction treatment for newly diagnosed Multiple Myeloma (MM) is associated with a lower rate of Second Primary Malignancies (SPMs) compared to Thalidomide-Dexamethasone (TD)

被引：0
|
作者：
Brioli, A. [1 ,2 ]
Pezzi, A. [2 ]
Muegge, L-O [1 ]
Derudas, D. [3 ]
Petti, M. C. [4 ]
Zannetti, B. A. [2 ]
Ferrara, F. [5 ]
Rocchi, S. [2 ]
Nobile, F. [6 ]
Baraldi, A. [7 ]
Musto, P. [8 ]
Lanza, F. [9 ]
Mancuso, K. [2 ]
Canepa, L. [10 ]
Catalano, L. [5 ]
Lazzaro, A. [11 ]
Pinotti, G. [12 ]
Boccadoro, M. [13 ]
Hochhaus, A. [1 ]
Cavo, M. [2 ]
机构：
[1] Univ Klinikum Jena, Klin Innere Med 2, Hamatol & Internist Onkol, Jena, Germany
[2] Univ Bologna, Seragnoli Inst Hematol, Sch Med, Bologna, Italy
[3] GIMEMA, Italian Myeloma Network, Cagliari, Italy
[4] GIMEMA, Italian Myeloma Network, Rome, Italy
[5] GIMEMA, Italian Myeloma Network, Naples, Italy
[6] GIMEMA, Italian Myeloma Network, Reggio Di Calabria, Italy
[7] GIMEMA, Italian Myeloma Network, Alessandria, Italy
[8] GIMEMA, Italian Myeloma Network, Rionero In Vulture, Italy
[9] GIMEMA, Italian Myeloma Network, Cremona, Italy
[10] GIMEMA, Italian Myeloma Network, Genoa, Italy
[11] GIMEMA, Italian Myeloma Network, Piacenza, Italy
[12] GIMEMA, Italian Myeloma Network, Varese, Italy
[13] GIMEMA, Italian Myeloma Network, Turin, Italy
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P239
引用
收藏
页码：69 / 69
页数：1
相关论文
共 50 条
  • [31] Subcutaneous Administration of Bortezomib in Combination with Thalidomide and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma Patients
    Wu, Shenghao
    Zheng, Cuiping
    Chen, Songyan
    Cai, Xiaoping
    Shi, Yuejian
    Lin, Bijing
    Chen, Yuemiao
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [32] IMPACT OF CONSOLIDATION WITH BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE (VTD) UPFRONT IN MULTIPLE MYELOMA (MM) WITH PARTIAL RESPONSE (PR) AT COMPLETION OF INDUCTION WITH VTD
    Fouquet, G.
    Hebraud, B.
    Garciaz, S.
    Stoppa, A. M.
    Roussel, M.
    Caillot, D.
    Chretien, M. L.
    Arnulf, B.
    Szalat, R.
    Garderet, L.
    Benajiba, L.
    Pegourie, B.
    Regny, C.
    Royer, B.
    Caulier, A.
    Touzeau, C.
    Tessoulin, B.
    Fermand, J. P.
    Facon, T.
    Attal, M.
    Avet-Loiseau, H.
    Moreau, P.
    Leleu, X.
    [J]. HAEMATOLOGICA, 2014, 99 : 367 - 367
  • [33] Thalidomide-dexamethasone versus Interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study
    Offidani, Massimo
    Corvatta, Laura
    Polloni, Claudia
    Piersantelli, Maria-Novella
    Gentili, Silvia
    Galieni, Piero
    Visani, Giuseppe
    Alesiani, Francesco
    Catarini, Massimo
    Brunori, Marino
    Samori, Arduino
    Burattini, Maurizio
    Centurioni, Riccardo
    Ferranti, Mario
    Giuliodori, Luciano
    Candela, Marco
    Mele, Anna
    Marconi, Monica
    Leoni, Pietro
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (05) : 653 - 659
  • [34] CKS1B over-expression significantly predicts for a lower rate of response to primary therapy with thalidomide-dexamethasone (Thali-Dex) for newly diagnosed multiple myeloma (MM) patients.
    Renzulli, Matteo
    Terragna, C.
    Testoni, N.
    Montanari, E.
    Tosi, P.
    Zamagni, E.
    Tacchetti, P.
    Perrone, G.
    Martinelli, Giovanni
    Baccarani, M.
    Cavo, M.
    [J]. BLOOD, 2006, 108 (11) : 114A - 114A
  • [35] Autologous Peripheral Blood Stem-Cell (PBSC) Collection Is Not Impaired by Bortezomib-Thalidomide-Dexamethasone (VTD) Induction Therapy in Newly Diagnosed Multiple Myeloma (MM)
    Brioli, Annamaria
    Perrone, Giulia
    Volpe, Silvestro
    Pasini, Silvana
    Mele, Anna
    Rossini, Fausto
    Liberati, Anna Marina
    De Rosa, Luca
    Avvisati, Giuseppe
    Amadori, Sergio
    Gozzetti, Alessandro
    Capaldi, Antonio
    Mele, Giuseppe
    Farina, Giuliana
    Zamagni, Elena
    Vigna, Ernesto
    Capalbo, Silvana
    Magni, Michele
    Nunziata, Giuseppe Rodolfo
    Crugnola, Monica
    Fregoni, Vittorio
    Leopardi, Giuliana
    Attolico, Immacolata
    Moscetti, Alessandro
    Podda, Luigi
    Pregno, Patrizia
    Baccarani, Michele
    Cavo, Michele
    [J]. BLOOD, 2011, 118 (21) : 148 - 148
  • [36] Retrospective comparison of transplant outcomes in patients with multiple myeloma according to induction therapy with thalidomide/dexamethasone (TD) with or without bortezomib (VTD)
    Giralt, Sergio
    Thandi, Rupi
    Qazilbash, Muzaffar
    Mendoza, Floralyn
    Han, Eric
    Hosing, Chitra
    Wang, Michael
    Thomas, Sheeba
    Alexanian, Raymond
    Champlin, Richard
    Weber, Donna
    [J]. BLOOD, 2007, 110 (11) : 288A - 288A
  • [37] Superior complete remission/very good partial remission rate with peri-transplant administration of thalidomide-dexamethasone for newly diagnosed multiple myeloma.
    Cavo, M
    Zamagni, E
    Tosi, P
    Cangini, D
    Tacchetti, P
    Cellini, C
    Testoni, N
    Nicci, C
    de Vivo, A
    Perrone, G
    Ceccolini, M
    Baccarani, M
    [J]. BLOOD, 2005, 106 (11) : 456B - 456B
  • [38] Bortezomib, dexamethasone plus thalidomide for treatment of newly diagnosed multiple myeloma patients with or without renal impairment
    Guangzhong Yang
    Wenming Chen
    Yin Wu
    [J]. Chinese Journal of Cancer Research, 2013, 25 (02) : 155 - 160
  • [39] Bortezomib, dexamethasone plus thalidomide for treatment of newly diagnosed multiple myeloma patients with or without renal impairment
    Yang, Guangzhong
    Chen, Wenming
    Wu, Yin
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (02) : 155 - 160
  • [40] Induction Treatment With Cyclophosphamide, Thalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: A Phase II Study
    Yang, Deok-Hwan
    Kim, Yeo-Kyeoung
    Sohn, Sang-Kyun
    Chung, Joo-Seop
    Joo, Young-Don
    Lee, Jae-Hoon
    Lee, Jung-Lim
    Ahn, Jae-Sook
    Moon, Joon-Ho
    Shin, Ho-Jin
    Choi, Young-Jin
    Lee, Won-Sik
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (01): : 62 - 67
12345